Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: Steve Harmon who wrote (1942)	2/26/1999 11:57:00 AM
From: Walter Morton	Read Replies (1) \| Respond to of 2742

''We believe that the sale of our research product line will allow us to focus our business on therapeutic applications for IL-1 beta. As we have announced previously, we are continuing the process of seeking to enhance shareholder value through strategic or other business combinations, including a sale or merger of Cistron or partnerships for product development, and believe that our narrowed focus on therapeutic applications of IL-1 beta will enhance that effort,'' stated Bruce C. Galton, Cistron CEO and chairman." go2net.newsalert.com